全文获取类型
收费全文 | 1258篇 |
免费 | 140篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 20篇 |
妇产科学 | 43篇 |
基础医学 | 136篇 |
口腔科学 | 113篇 |
临床医学 | 136篇 |
内科学 | 342篇 |
皮肤病学 | 10篇 |
神经病学 | 73篇 |
特种医学 | 89篇 |
外科学 | 124篇 |
综合类 | 20篇 |
预防医学 | 130篇 |
眼科学 | 4篇 |
药学 | 124篇 |
肿瘤学 | 34篇 |
出版年
2023年 | 13篇 |
2021年 | 18篇 |
2020年 | 22篇 |
2019年 | 21篇 |
2018年 | 27篇 |
2017年 | 27篇 |
2016年 | 27篇 |
2015年 | 27篇 |
2014年 | 34篇 |
2013年 | 42篇 |
2012年 | 58篇 |
2011年 | 60篇 |
2010年 | 46篇 |
2009年 | 44篇 |
2008年 | 43篇 |
2007年 | 47篇 |
2006年 | 43篇 |
2005年 | 47篇 |
2004年 | 42篇 |
2003年 | 39篇 |
2002年 | 41篇 |
2001年 | 44篇 |
2000年 | 37篇 |
1999年 | 36篇 |
1998年 | 30篇 |
1997年 | 26篇 |
1996年 | 22篇 |
1995年 | 15篇 |
1994年 | 19篇 |
1993年 | 14篇 |
1992年 | 13篇 |
1991年 | 17篇 |
1990年 | 24篇 |
1989年 | 32篇 |
1988年 | 23篇 |
1987年 | 23篇 |
1986年 | 24篇 |
1985年 | 16篇 |
1984年 | 17篇 |
1983年 | 21篇 |
1982年 | 11篇 |
1981年 | 18篇 |
1980年 | 10篇 |
1979年 | 14篇 |
1978年 | 17篇 |
1977年 | 14篇 |
1976年 | 14篇 |
1975年 | 9篇 |
1974年 | 13篇 |
1972年 | 9篇 |
排序方式: 共有1401条查询结果,搜索用时 46 毫秒
31.
32.
33.
Tara Donker Katherine Petrie Judy Proudfoot Janine Clarke Mary-Rose Birch Helen Christensen 《Journal of medical Internet research》2013,15(11)
Background
The rapid growth in the use of mobile phone applications (apps) provides the opportunity to increase access to evidence-based mental health care.Objective
Our goal was to systematically review the research evidence supporting the efficacy of mental health apps for mobile devices (such as smartphones and tablets) for all ages.Methods
A comprehensive literature search (2008-2013) in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, PsycINFO, PsycTESTS, Compendex, and Inspec was conducted. We included trials that examined the effects of mental health apps (for depression, anxiety, substance use, sleep disturbances, suicidal behavior, self-harm, psychotic disorders, eating disorders, stress, and gambling) delivered on mobile devices with a pre- to posttest design or compared with a control group. The control group could consist of wait list, treatment-as-usual, or another recognized treatment.Results
In total, 5464 abstracts were identified. Of those, 8 papers describing 5 apps targeting depression, anxiety, and substance abuse met the inclusion criteria. Four apps provided support from a mental health professional. Results showed significant reductions in depression, stress, and substance use. Within-group and between-group intention-to-treat effect sizes ranged from 0.29-2.28 and 0.01-0.48 at posttest and follow-up, respectively.Conclusions
Mental health apps have the potential to be effective and may significantly improve treatment accessibility. However, the majority of apps that are currently available lack scientific evidence about their efficacy. The public needs to be educated on how to identify the few evidence-based mental health apps available in the public domain to date. Further rigorous research is required to develop and test evidence-based programs. Given the small number of studies and participants included in this review, the high risk of bias, and unknown efficacy of long-term follow-up, current findings should be interpreted with caution, pending replication. Two of the 5 evidence-based mental health apps are currently commercially available in app stores. 相似文献34.
Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure
下载免费PDF全文
![点击此处可从《European journal of heart failure》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Rasmus Rørth Emil L. Fosbøl Ulrik M. Mogensen Kristian Kragholm Anna‐karin Numé Gunnar H. Gislason Pardeep S. Jhund Mark C. Petrie John J.V. McMurray Christian Torp‐Pedersen Lars Køber Søren L. Kristensen 《European journal of heart failure》2018,20(2):240-247
Aims
Employment status at time of first heart failure (HF) hospitalization may be an indicator of both self‐perceived and objective health status. In this study, we examined the association between employment status and the risk of all‐cause mortality and recurrent HF hospitalization in a nationwide cohort of patients with HF.Methods and results
We identified all patients of working age (18–60 years) with a first HF hospitalization in the period 1997–2015 in Denmark, categorized according to whether or not they were part of the workforce at time of the index admission. The primary outcome was death from any cause and the secondary outcome was readmission for HF. Cumulative incidence curves, binomial regression and Cox regression models were used to assess outcomes. Of 25 571 patients with a first hospitalization for HF, 15 428 (60%) were part of the workforce at baseline. Patients in the workforce were significantly younger (53 vs. 55 years) more likely to be male (75% vs 64%) and less likely to have diabetes (13% vs 22%) and chronic obstructive pulmonary disease (5% vs 10%) (all P < 0.0001). Not being part of the workforce was associated with a significantly higher risk of death [hazard ratio (HR) 1.59; 95% confidence interval (CI) 1.50–1.68] and rehospitalization for HF (HR 1.09; 95% CI 1.05–1.14), in analyses adjusted for age, sex, co‐morbidities, education level, calendar time, and duration of first HF hospitalization.Conclusion
Not being part of the workforce at time of first HF hospitalization was independently associated with increased mortality and recurrent HF hospitalization.35.
36.
A non-human primate antiserum was prepared to acute lymphoblastic leukemia of T-cell phenotype (T-ALL) and, after absorptions with normal blood elements, reacted by immunofluorescence and microcytotoxicity to all the T-ALL tested. In addition, the antiserum reacted with cells from about 70% of the common ALL studied and immunoprecipitated the common ALL antigen of 100,000 daltons. However, when the anti-T-ALL serum was absorbed with with lymphoblasts from common ALL, it failed to react with common ALL lymphoblasts, yet reacted significantly with cells from patients with T-ALL phenotype and defined a 100,000-dalton membrane component not found on common ALL lymphoblasts. In addition, sequential immunoprecipitation of 125I-labeled T-ALL membranes by anti- common-ALL serum followed by anti-T-ALL serum detected the T-ALL membrane component of 100,000 daltons that was not found on common ALL. Thus, our results demonstrate the presence of of a unique human T-ALL antigen present on all T-ALL distinct from the common ALL antigen. 相似文献
37.
Amplification of genes encoding human myeloid membrane antigens after DNA-mediated gene transfer 总被引:2,自引:0,他引:2
Spontaneous amplification of genes encoding two different human myeloid surface antigens was observed after DNA-mediated gene transfer of cellular DNA from the human myeloid cell line HL-60 into NIH-3T3 mouse fibroblasts. Transformed recipient cells with highly amplified expression of either of two donor membrane polypeptides, gp150 or p67, were isolated with a fluorescence-activated cell sorter (FACS), using monoclonal antibodies specific for human myeloid cells. Immunoprecipitation of enzymatically radioiodinated polypeptides from the surface of transformed NIH-3T3 cells confirmed that expression of these proteins was amplified tenfold to 20-fold in comparison to their expression on human myeloid cell lines. The cellular DNA of cloned secondary and tertiary transformants expressing high levels of gp150 and p67 contained amplified sets of DNA restriction fragments that hybridized with human repetitive DNA sequences. Cytogenetic analysis of subclones overexpressing gp150 revealed extrachromosomal double minutes (DMs), whose presence correlated with the unstable expression of the membrane polypeptide. Human sequences in gp150-positive clones did not localize to chromosomes, consistent with their association with extrachromosomal DMs. By contrast, p67-positive subclones stably expressed the antigen, and in situ hybridization to metaphase spreads demonstrated that amplified human DNA sequences were integrated into a specific marker chromosome. Cytogenetic analysis of the parental NIH- 3T3 subclone used in these studies disclosed DMs in a low percentage of metaphases, suggesting that the recipient cells have a propensity for amplifying donor DNA. 相似文献
38.
Petrie EC Peskind ER Dobie DJ Veith RC Raskind MA 《The journals of gerontology. Series A, Biological sciences and medical sciences》2000,55(3):M155-M159
BACKGROUND: The effects of aging on sympathetic nervous system and adrenomedullary outflow were estimated by the measurement of plasma norepinephrine (NE) and epinephrine (EPI) responses to yohimbine and clonidine in healthy young and healthy older subjects. METHODS: Yohimbine (0.65 mg/kg), clonidine (5 microg/kg), and placebo were administered on separate days in random order to 5 healthy older men (age 74 +/- 1 years) and 18 healthy young men (age 26 +/- 1 years). NE and EPI were measured by radioenzymatic assay in plasma samples obtained before and 30, 60, and 90 minutes after drug administration. RESULTS: Plasma NE increases after yohimbine were greater in older men than in young men. but plasma NE decreases following clonidine did not differ between groups. Plasma NE and systolic blood pressure were higher in older men than in young men at baseline but no longer differed 90 minutes after clonidine. Plasma EPI increases after yohimbine and decreases after clonidine did not differ between groups. CONCLUSIONS: These results suggest increased sympathetic nervous system outflow in human aging that is not a function of reduced responsiveness of alpha-2 adrenoreceptor-mediated feedback inhibition. 相似文献
39.
Karen Sliwa Denise Hilfiker‐Kleiner Alexandre Mebazaa Mark C. Petrie Aldo P. Maggioni Vera Regitz‐Zagrosek Maria Schaufelberger Luigi Tavazzi Dirk J. van Veldhuisen Jolien W. Roos‐Hesslink Ajay J. Shah Petar M. Seferovic Uri Elkayam Karin van Spaendonck‐Zwarts Katrin Bachelier‐Walenta Frederic Mouquet Elisabeth Kraigher‐Krainer Roger Hall Piotr Ponikowski John J. V. McMurray Burkert Pieske 《European journal of heart failure》2014,16(5):583-591
40.
Kieran F. Docherty Li Shen Davide Castagno Mark C. Petrie William T. Abraham Michael Bhm Akshay S. Desai Kenneth Dickstein Lars V. Kber Milton Packer Jean L. Rouleau Scott D. Solomon Karl Swedberg Ali Vazir Michael R. Zile Pardeep S. Jhund John J.V. McMurray 《European journal of heart failure》2020,22(3):528-538